U.S., June 28 -- ClinicalTrials.gov registry received information related to the study (NCT07041372) titled 'Cerebral Atherosclerosis Research With Positron Emission Tomography' on June 19.
Brief Summary: The goal of this clinical trial is to learn if the application of fluorodeoxyglucose positron emission tomography can predict prognosis of stroke patients. The main questions it aims to answer are:
* Does FDG PET can predict future vascular events such as stroke recurrence, myocardial infarction or vascular death among stroke survivors?
* Does FDG PET can predict other important events such as fracture, dementia, bleeding, cancer and overall death among stroke survivors? Researchers will compare the FDG uptake in major organs - such as ...